Mr. Ilya Kuntsevich is the President at Avant-Garde Corporation.

Avant-Garde Corporation executes capital-raising engagements and performs private placement activities involving securities and investment products.

Mr. Kuntsevich is a strategic finance leader with 3 decades of experience driving growth across financial services, technology, life sciences, and alternative investments. He co-founded Beverly Investment Group, served as CFO of life sciences venture CRI Genetics through IPO planning, and is a veteran of EY, Virtu Financial, and Aurora Capital Group. 

Mr. Kuntsevich earned an MBA from the UCLA Anderson School of Management with certifications in Finance and Advanced International Management. 

Mr. Kuntsevich holds the Series 7 and 63 registrations with FINRA.